Company / Operating Income
Sagimet Biosciences Inc. Operating Income History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$30.7M
FY2024
5-year range
-$31.1M / -$30.7M
FY2023-FY2024
Trend
+1.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$31M in FY2024.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income increased 1.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$30.7M | +1.0% |
| FY2023 | -$31.1M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026